Literature DB >> 24402374

miR-511 induces the apoptosis of radioresistant lung adenocarcinoma cells by triggering BAX.

Han-Han Zhang1, Min Pang1, Wei Dong2, Jia-Xuan Xin1, You-Jie Li1, Zi-Cheng Zhang2, Liang Yu3, Ping-Yu Wang1, Bao-Sheng Li4, Shu-Yang Xie1.   

Abstract

Radioresistance is one of the main reasons for the failure of radiotherapy in lung cancer. The present study was conducted to identify the role of miR-511 in suppressing the growth of radioresistant lung adenocarcinoma cells. First, a radioresistant A549/R cell line was generated after prolonged exposure to X-rays for 68 Gy (2 Gy/day, 5 days/week) and the radioresistance was confirmed by wound healing assay. Next, oncogenic TRIB2 was found to be upregulated in the radioresistant A549/R cells when compared to that of the control A549 cells as determined by western blot analysis. As the upstream miRNA, quantitative PCR showed that miR-511 expression was decreased in the radioresistant A549/R cells. Overexpression of miR-511 in miR-511-transfected A549/R cells inhibited cell growth and increased the number of apoptotic cells when compared with the control treatment. Flow cytometric analysis further demonstrated that the growth suppressive effect of miR-511 on A549/R cells was mediated by regulation of the cell cycle, most likely due to a block in the G1-S transition. Finally, our results showed that the expression of BAX was lower in the radioresistant A549/R cells when compared with that in the control A549 cells. After downregulation of TRIB2 by miR-511 treatment, BAX expression was obviously increased in the miR-511-transfected apoptotic A549/R cells when compared to that in the NC-treated or control cultures. In summary, our results revealed that miR-511 regulates the growth of radioresistant A549/R cells by increasing BAX expression through TRIB2, which suggests that miR-511 may be a potential therapeutic molecule for the treatment of radioresistant lung adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24402374     DOI: 10.3892/or.2014.2973

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  14 in total

1.  MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals.

Authors:  Qing Lv; Jin-Xia Hu; You-Jie Li; Ning Xie; Dan Dan Song; Wei Zhao; Yun-Fei Yan; Bao-Sheng Li; Ping-Yu Wang; Shu-Yang Xie
Journal:  Cancer Biol Ther       Date:  2017-01-20       Impact factor: 4.742

2.  miR-511 promotes the proliferation of human hepatoma cells by targeting the 3'UTR of B cell translocation gene 1 (BTG1) mRNA.

Authors:  Shu-Qin Zhang; Zhe Yang; Xiao-Li Cai; Man Zhao; Ming-Ming Sun; Jiong Li; Guo-Xing Feng; Jin-Yan Feng; Li-Hong Ye; Jun-Qi Niu; Xiao-Dong Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-06-12       Impact factor: 6.150

Review 3.  BANCR: a cancer-related long non-coding RNA.

Authors:  Xin Yu; Heyi Zheng; Matthew Tv Chan; William Ka Kei Wu
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

4.  Acquisition of radioresistance in docetaxel-resistant human lung adenocarcinoma cells is linked with dysregulation of miR-451/c-Myc-survivin/rad-51 signaling.

Authors:  Rui Wang; Dong-Qin Chen; Jia-Yuan Huang; Kai Zhang; Bing Feng; Ban-Zhou Pan; Jing Chen; Wei De; Long-Bang Chen
Journal:  Oncotarget       Date:  2014-08-15

5.  Reduced expression levels of let-7c in human breast cancer patients.

Authors:  Xin-Xin Li; Shu-Yan Gao; Ping-Yu Wang; Xue Zhou; You-Jie Li; Yuan Yu; Yun-Fei Yan; Han-Han Zhang; Chang-Jun Lv; Hui-Hui Zhou; Shu-Yang Xie
Journal:  Oncol Lett       Date:  2015-01-14       Impact factor: 2.967

6.  LncRNA-RMRP Acts as an Oncogene in Lung Cancer.

Authors:  Qingjun Meng; Mingming Ren; Yanguang Li; Xiang Song
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

7.  Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer.

Authors:  Ziling Fang; Ling Zhang; Quan Liao; Yi Wang; Feng Yu; Miao Feng; Xiaojun Xiang; Jianping Xiong
Journal:  J Exp Clin Cancer Res       Date:  2017-01-23

Review 8.  MicroRNAs Involvement in Radioresistance of Head and Neck Cancer.

Authors:  Parwez Ahmad; Jiri Sana; Marek Slavik; Pavel Slampa; Pavel Smilek; Ondrej Slaby
Journal:  Dis Markers       Date:  2017-02-23       Impact factor: 3.434

Review 9.  Tissue-specific and exosomal miRNAs in lung cancer radiotherapy: from regulatory mechanisms to clinical implications.

Authors:  Long Long; Xue Zhang; Jian Bai; Yizhou Li; Xiaolong Wang; Yunfeng Zhou
Journal:  Cancer Manag Res       Date:  2019-05-13       Impact factor: 3.989

Review 10.  Role of long non-coding RNA in drug resistance in non-small cell lung cancer.

Authors:  Leirong Wang; Leina Ma; Fei Xu; Wenxin Zhai; Shenghua Dong; Ling Yin; Jia Liu; Zhuang Yu
Journal:  Thorac Cancer       Date:  2018-05-03       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.